Classical papillary
The standard, most frequent form. Slow-growing and well-differentiated, it carries the favourable prognosis most people associate with papillary thyroid cancer.
The most common, most treatable thyroid cancer
Papillary thyroid cancer — a hopeful diagnosis
Medically reviewed by Dr. Owais Mohammed, Medical Oncologist, MBBS · MD · Last reviewed June 2026
Papillary thyroid cancer (PTC), also called papillary thyroid carcinoma, is the most common type of thyroid cancer — and one of the most treatable of all cancers. It usually grows slowly, responds well to treatment, and carries an excellent prognosis. Understanding what it is helps you take the next step calmly.
- About 8 in 10 thyroid cancers — papillary is by far the most common type
- Slow-growing and well-differentiated — it behaves much like normal thyroid tissue
- Excellent prognosis — over 99% five-year survival when found early
- Clear treatment pathway — surgery, selective RAI, and simple follow-up
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What Is Papillary Thyroid Cancer (PTC)?
The thyroid is a small, butterfly-shaped gland at the base of the neck that controls how your body uses energy. Papillary thyroid cancer — also written as papillary thyroid carcinoma, or PTC — is a cancer that starts in the follicular cells of this gland. It is by far the most common type of thyroid cancer, accounting for roughly 8 in 10 cases.
PTC is described as a well-differentiated cancer. That simply means the cancer cells still look and behave much like normal thyroid cells. Because of this, it tends to grow slowly, and when it does spread it usually travels only to nearby lymph nodes in the neck rather than to distant organs.
If you have just been told you have papillary thyroid cancer, the most important thing to know is that this is one of the most treatable of all cancers. A clear diagnosis is the start of a well-mapped pathway — not a reason to panic. We walk this journey with you, one step at a time.
Did you know?
Papillary thyroid cancer found while it is still within the thyroid or nearby neck lymph nodes has a five-year survival rate of over 99% — one of the highest of any cancer. Most people are cured. (Source: SEER survival data / NCCN Clinical Practice Guidelines in Oncology — Thyroid Carcinoma.)
Variants of PTC
Most common
Very low risk
Follicular pattern
Watched closely
Common Variants of Papillary Thyroid Carcinoma
Papillary thyroid cancer has several variants. Most behave the same way and share the same excellent outlook; a few are watched a little more closely. Your pathology report will name which variant you have.
Papillary microcarcinoma
A tumour 1 cm or smaller. Often found by chance, it is so low-risk that very small, confined ones may sometimes be monitored rather than operated on straight away.
Follicular variant
Grows in a follicular pattern but is still papillary cancer. Generally behaves and is treated like classical PTC, with a similarly good outlook.
Tall-cell & other variants
A few uncommon variants, such as tall-cell, can be slightly more active. They are still highly treatable but may warrant closer monitoring and a more thorough plan.
What Affects the Prognosis of PTC?
The overall outlook for papillary thyroid cancer is excellent, but a few factors help your specialist judge your individual prognosis and decide how much treatment is right for you.
Tumour size and spread. Smaller tumours that are still within the thyroid have the best outlook. Spread to neck lymph nodes is common with PTC and, reassuringly, still carries a very good prognosis when treated.
Your age at diagnosis. Younger patients generally have an even more favourable outlook than older patients — age is one of the main factors used in thyroid cancer staging.
Because outcomes are so good, the aim of papillary thyroid cancer treatment is usually a lasting cure with the fewest possible side-effects — not aggressive, one-size-fits-all treatment. Speak to a CION thyroid cancer specialist to understand what your own report means.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A PTC Diagnosis Deserves an Unhurried Conversation
Papillary thyroid cancer is highly treatable — but the right plan is the one made for you, by a team. We give you a 45-minute consultation, a tumour-board review, and no unnecessary tests.
How Papillary Thyroid Cancer Is Diagnosed
Diagnosing papillary thyroid cancer follows a clear, step-by-step pathway. Each step is simple, and together they confirm the diagnosis before any treatment plan is made.
Examination and neck ultrasound
Your specialist examines your neck and arranges an ultrasound — a quick, painless scan that looks closely at the thyroid nodule and checks the neck lymph nodes. It is the single most useful first test.
Fine needle aspiration (FNAC)
If a nodule looks suspicious, a fine needle aspiration cytology takes a small sample of cells using a very thin needle. It is a brief outpatient test and is the main way papillary thyroid cancer is confirmed.
Blood tests and, if needed, further scans
Thyroid function blood tests check how the gland is working. In some cases additional imaging is done to map the extent of the cancer before surgery — but only when it genuinely adds value.
Tumour board review and staging
Your results are reviewed by a multidisciplinary tumour board. Together they confirm the stage and agree the right, personalised treatment plan — not one doctor's opinion alone.
Did you know?
Spread to neck lymph nodes is common in papillary thyroid cancer — yet, unlike many other cancers, it does not greatly change the excellent overall outlook. It is treated as part of the standard plan, not a cause for alarm. (Source: NCCN Clinical Practice Guidelines in Oncology — Thyroid Carcinoma.)
PTC prognosis treatment
How Papillary Thyroid Cancer Is Treated
Treatment for papillary thyroid carcinoma is matched to the size and spread of your tumour. Most people need surgery; some need a little more, and a few need very little. Your tumour board decides what is right for you.
Surgery (thyroidectomy)
The main treatment. A lobectomy removes half the thyroid for small, low-risk tumours; a total thyroidectomy removes the whole gland for larger or higher-risk disease.
Radioactive iodine (RAI)
A swallowed capsule that targets any remaining thyroid cells. Used selectively — for larger tumours or node spread — and not needed for many small, low-risk papillary cancers.
Thyroid hormone tablets
After surgery, most patients take a daily thyroid hormone tablet. It replaces the gland's normal function and, at the right dose, helps lower the chance of the cancer returning.
Active surveillance
For a small group with tiny, low-risk papillary cancers, careful monitoring with regular ultrasounds — instead of immediate surgery — can be a safe and appropriate choice.
You can read about the full pathway, including recovery, on our thyroid cancer treatment in Hyderabad page.
Life After Treatment — Follow-Up and Recurrence
Because papillary thyroid cancer grows slowly and responds so well to treatment, the focus after surgery is on simple, long-term follow-up rather than intensive treatment.
Regular monitoring. Follow-up usually includes neck ultrasounds and a blood test for thyroglobulin — a protein that acts as a marker for thyroid tissue. A stable, low result is reassuring; a rising level or a new finding prompts a closer look.
If it ever returns. Recurrence is uncommon, and most often appears in the neck lymph nodes where it is readily treatable. Found on follow-up, even a recurrence of papillary thyroid cancer usually has a very good outlook.
For most people, life after PTC treatment is normal — a daily tablet, periodic check-ups, and the confidence that comes from being followed by a team.
Why Patients Choose CION for Papillary Thyroid Cancer
If you want your diagnosis understood properly — and treated with exactly the right amount of care, no more and no less — here is what to expect at CION.
- Free 45-minute consultation — unhurried time to explain your report and answer every question
- Tumour board for every patient — your plan is agreed by a team, not one doctor's opinion
- No unnecessary tests or treatment, ever — RAI and extra scans are used only when they genuinely help
- Care led by a team — medical, surgical and radiation oncologists working together
- 35+ centres across Telangana & AP — care close to home, with less travel
- Free written second opinion — bring an existing report and have it reviewed at no cost
A papillary thyroid cancer diagnosis is a hopeful one. Book a free consultation and take the next step with a team beside you.
From our patients
People Treated for Thyroid Cancer — and What Happened Next
Real stories from patients who were newly diagnosed, got a clear plan, and walked the journey with our team.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Papillary Thyroid Cancer — Your Questions Answered
What is papillary thyroid cancer?
Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, making up about 8 in 10 of all cases. It begins in the follicular cells of the thyroid gland, a small butterfly-shaped gland at the base of the neck. PTC is described as a well-differentiated cancer, meaning the cells still look and behave much like normal thyroid cells. It usually grows slowly and, when it spreads, tends to involve nearby lymph nodes in the neck rather than distant organs. Because it is slow-growing and responds well to treatment, papillary thyroid carcinoma carries one of the most favourable prognoses of any cancer.
How serious is papillary thyroid cancer?
Papillary thyroid cancer is one of the most treatable of all cancers. Most cases are slow-growing and confined to the thyroid or nearby neck lymph nodes when found, and the great majority of patients are cured. Published survival data show that early-stage papillary thyroid cancer has a five-year survival rate of over 99%. Serious cases are uncommon and tend to involve larger tumours, spread beyond the neck, or older age at diagnosis. Even then, a clear, staged treatment plan offers excellent outcomes for most people, which is why an unhurried specialist assessment matters so much.
What is the prognosis and survival rate for PTC?
The prognosis for papillary thyroid carcinoma is excellent, especially when it is found early. For cancer that is still within the thyroid or limited to nearby neck lymph nodes, the five-year survival rate is over 99% in published data. Prognosis depends on factors such as the size of the tumour, whether it has spread beyond the neck, and your age at diagnosis. Younger patients generally have a better outlook. Because outcomes are so favourable, the focus of PTC treatment is usually on long-term cure with the least possible side-effect, rather than aggressive treatment.
How is papillary thyroid cancer diagnosed?
Papillary thyroid cancer is usually diagnosed in a clear sequence of simple steps. It begins with a clinical examination of the neck, followed by a neck ultrasound to look closely at the thyroid nodule and any neck lymph nodes. If the nodule looks suspicious, a fine needle aspiration cytology (FNAC) is done — a quick test using a very thin needle to sample cells from the lump. The cells are then examined under a microscope to confirm the diagnosis. Blood tests for thyroid function and, in some cases, additional scans help complete the picture before a treatment plan is made.
How is papillary thyroid cancer treated?
Treatment for papillary thyroid cancer is tailored to the size and spread of the tumour and is decided by a tumour board. The main treatment is surgery — either removing half the thyroid (lobectomy) for small, low-risk tumours, or the whole gland (total thyroidectomy) for larger or higher-risk disease. After surgery, some patients receive radioactive iodine (RAI) therapy to clear any remaining thyroid tissue, and most take thyroid hormone tablets daily. For selected very small, low-risk tumours, careful active surveillance may be an option. Your specialist will explain which approach fits your individual situation.
Do I always need my whole thyroid removed for PTC?
No — not everyone with papillary thyroid cancer needs the whole gland removed. For small, low-risk tumours confined to one side of the thyroid, removing only that lobe (a lobectomy) is often enough and may let you keep normal thyroid function without lifelong tablets. Larger tumours, cancer in both lobes, or spread to lymph nodes usually need a total thyroidectomy. For a very small group with tiny, low-risk papillary cancers, active surveillance — close monitoring instead of immediate surgery — can be appropriate. The right choice is made together with your tumour board, balancing cure with quality of life.
What is radioactive iodine (RAI) therapy and will I need it?
Radioactive iodine (RAI) therapy is a treatment given after thyroid surgery, in which you swallow a capsule of radioactive iodine. Thyroid cells absorb iodine, so the treatment targets and destroys any remaining thyroid tissue or cancer cells while sparing the rest of the body. Not everyone with papillary thyroid cancer needs RAI — it is used selectively for larger tumours, spread to lymph nodes, or a higher risk of recurrence. Many patients with small, low-risk papillary cancers do not need it at all. Your specialist will recommend RAI only when the benefit is clear, in keeping with our no-unnecessary-treatment approach.
Can papillary thyroid cancer come back after treatment?
Papillary thyroid cancer can occasionally return, most often in the lymph nodes of the neck, but recurrence is uncommon and usually treatable when it happens. This is why follow-up after treatment is important. Monitoring typically includes regular neck ultrasounds and a blood test for thyroglobulin — a protein that acts as a marker for thyroid tissue. A rising thyroglobulin level or a new lump on ultrasound prompts further checks. Because PTC grows slowly and responds well to treatment, even a recurrence found on follow-up usually has a very good outlook.
Is papillary thyroid cancer hereditary?
Most papillary thyroid cancers are not inherited — they occur sporadically, with no clear cause that you could have prevented. A minority of cases run in families, and the risk is higher if a close relative has had thyroid cancer or if you have had radiation to the head or neck, particularly in childhood. If several family members have had thyroid cancer, your specialist may discuss family screening. For the great majority of people, however, papillary thyroid cancer is a one-off event and not something passed on to children.
Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your situation. This page is periodically reviewed and updated by CION's medical team in line with current clinical guidelines.